Merck — Drug Prices & Medicare Spending

Merck manufactures 18 drugs tracked by Medicare Part D with total spending of $13.7B.

Drugs Tracked

$13.7B

Medicare Spending

$110.29

Avg Cost/Claim

89%

Have Generics

Merck Drugs — Ranked by Medicare Spending

#	Drug	Generic Name	Cost/Claim	Medicare Spending	YoY Change	Generic?
1	Keytruda	Pembrolizumab	$18,176.00	$7.2B	+28.6%	No
2	Januvia	Sitagliptin	$219.00	$2.7B	-12.3%	No
3	Janumet	Sitagliptin/Metformin	$180.00	$876.0M	-8.6%	Yes
4	Isentress	Raltegravir	$2,452.00	$456.0M	-14.2%	Yes
5	Dificid	Fidaxomicin	$1,391.00	$345.0M	+8.4%	Yes
6	Zetia	Ezetimibe	$21.00	$298.0M	-38.7%	Yes
7	Losartan	Losartan Potassium	$9.00	$234.0M	-28.4%	Yes
8	Noxafil	Posaconazole	$2,721.00	$234.0M	+4.2%	Yes
9	Steglatro	Ertugliflozin	$144.00	$178.0M	-12.3%	Yes
10	Verquvo	Vericiguat	$511.00	$178.0M	+56.3%	Yes
11	Vytorin	Ezetimibe/Simvastatin	$58.00	$145.0M	-34.2%	Yes
12	Singulair	Montelukast	$12.00	$145.0M	-38.4%	Yes
13	Montelukast	Montelukast Sodium	$13.00	$145.0M	-28.6%	Yes
14	Simvastatin	Simvastatin	$7.00	$123.0M	-34.6%	Yes
15	Finasteride	Finasteride	$10.00	$89.0M	-18.4%	Yes
16	Alendronate	Alendronate Sodium	$14.00	$89.0M	-28.6%	Yes
17	Dorzolamide-Timolol	Dorzolamide/Timolol	$36.00	$89.0M	-18.4%	Yes
18	Rizatriptan	Rizatriptan Benzoate	$27.00	$67.0M	-18.6%	Yes

Merck manufactures 18 drugs tracked by Medicare Part D, with total annual spending of $13.7B.

Keytruda (Pembrolizumab) is the most expensive at $18,176.00 per claim.

16 of 18 Merck drugs (89%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.